Pharmaceutical Companies: global shift Flashcards
central and eastern europe has high and unmet needs for ………………………….and……………….disease treatments
cardiovascular and respiratory disease treatement
which eastern european countries have a healthy R&D climate for drug developemnt?
- russia
- poland
- czech republic
- hungary
- turkey can produce ingredients and manufacture products
brazil is the latin american hub for……..
the brazilian government also favours………………….
brazil has potential for………….and………..
hub for FDI
gov. favours generic drugs, not brands
potential for CRO and CMO
argentina has potential for…..
gov. favours…………………..
market strategy is shifting to…………………..from…………………….
potential for R&D outsourcing
gov. favours generic drugs
market favours patients not doctors
india has…………..and…………………which is attractive to ………………. , ………… and …………………..
weak………….
preffered destination for …..outsourcing
highly skilled labour, low costs attractive to CRO, CMO and APIs
weak IP laws
R&D outsourcing
Singapore is in the ………………………………..FTA,
making it the manufacturing hub of the…………………….
US-Singapore free trade agreement
Asia-Pacific
singapore has highly competent facilities for
clinical trials
korea offers an
innovative capability and well developed pharmaceutical industry
china is the manufacting hub for….
API
china has an increasing competency for………………
china also has ……………..and………………….drugs as its fastest growing markets
also has improved ……..laws which will attract more……..
R&D outsourcing
anti-infectives and cardiovascular drugs
IP laws will attract more FDI
FTA=
free trade agreement
API=
application programming interface
CRO=
contract research organisation
CMO=
contract manufactuing organisaiton
FDA=
food and drug administration
